1.
Taçyıldız N, Tanyıldız HG, Ünal E, et al. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation. Turk J Pediatr. 2019;61(5):671-676. doi:10.24953/turkjped.2019.05.005